Nestle U - Search Results

1

Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.

Hellwig D, Gröschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM. Hellwig D, et al. Among authors: nestle u. Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):13-21. doi: 10.1007/s00259-005-1919-4. Epub 2005 Sep 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16151765 Clinical Trial.

2

[Tumor markers as prognostic factors in non-small-cell bronchial carcinoma].

Nieder C, Nestle U, Ukena D, Niewald M, Sybrecht GW, Schnabel K. Nieder C, et al. Among authors: nestle u. Strahlenther Onkol. 1995 Oct;171(10):587-93. Strahlenther Onkol. 1995. PMID: 8571178 German.

3

A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC).

Nestle U, Nieder C, Abel U, Niewald M, Ukena D, Berberich W, Schnabel K. Nestle U, et al. Radiother Oncol. 1996 Mar;38(3):195-203. doi: 10.1016/0167-8140(96)01706-9. Radiother Oncol. 1996. PMID: 8693099 Review.

4

18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis.

Nestle U, Walter K, Schmidt S, Licht N, Nieder C, Motaref B, Hellwig D, Niewald M, Ukena D, Kirsch CM, Sybrecht GW, Schnabel K. Nestle U, et al. Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):593-7. doi: 10.1016/s0360-3016(99)00061-9. Int J Radiat Oncol Biol Phys. 1999. PMID: 10348289

5

[Palliative accelerated irradiation for advanced non-small-cell lung bronchial carcinoma: results of a pilot study].

Nestle U, Nieder C, Walter K, Niewald M, Motaref B, Braun-Fischer A, Ukena D, Sybrecht GW, Schnabel K. Nestle U, et al. Pneumologie. 1999 Aug;53(8):385-92. Pneumologie. 1999. PMID: 10483277 Clinical Trial. German.

6

A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study.

Nestle U, Nieder C, Walter K, Abel U, Ukena D, Sybrecht GW, Schnabel K. Nestle U, et al. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):95-103. doi: 10.1016/s0360-3016(00)00607-6. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924977 Clinical Trial.

7

Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients.

Nestle U, Hellwig D, Fleckenstein J, Walter K, Ukena D, Rübe C, Kirsch CM, Baumann M. Nestle U, et al. Front Radiat Ther Oncol. 2002;37:26-33. doi: 10.1159/000061294. Front Radiat Ther Oncol. 2002. PMID: 11764664 No abstract available.

8

[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET].

Schmidt S, Nestle U, Walter K, Licht N, Ukena D, Schnabel K, Kirsch CM. Schmidt S, et al. Among authors: nestle u. Nuklearmedizin. 2002 Oct;41(5):217-20. Nuklearmedizin. 2002. PMID: 12418307 German.

9

2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer.

Nestle U, Hellwig D, Schmidt S, Licht N, Walter K, Ukena D, Rübe C, Baumann M, Kirsch CM. Nestle U, et al. Mol Imaging Biol. 2002 May;4(3):257-63. doi: 10.1016/s1536-1632(02)00005-7. Mol Imaging Biol. 2002. PMID: 14537131

10

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM. Nestle U, et al. J Nucl Med. 2005 Aug;46(8):1342-8. J Nucl Med. 2005. PMID: 16085592 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters